Skip to main content
. 2005 Jul 14;11(26):4013–4017. doi: 10.3748/wjg.v11.i26.4013

Table 2.

Virological and biochemical results

NYT (%) Control (%) P
Enrolled cases 10 13
Normal ALT at the end of therapy 7 (70.0) 6 (46.2) 0.253
Negative HCVRNA at the end of therapy 8 (80.0) 7 (53.8) 0.192
Normal ALT 6 mo after therapy 8 (80.0) 4 (30.8) 0.489
Negative HCVRNA 6 mo after therapy 4 (40.0) 4 (30.8) 0.645